Journals
Publish with us
Publishing partnerships
About us
Blog
Advances in Vascular Medicine
Table of Contents
Advances in Vascular Medicine
/
2014
/
Article
/
Tab 1
/
Research Article
The Impact of Warfarin on Patients with End Stage Renal Disease
Table 1
Comparison of the demographics and comorbidities of patients with end stage renal disease with and without warfarin from the 2005–2010 National Inpatient Sample.
ESRD with warfarin
ESRD without warfarin
Number
32,737
895,077
Demographics
Age in years ± SD
64.1 ± 15.7
61.1 ± 16.1
<0.001
Female (%)
49.0%
48.0%
NS
Caucasian (%)
54.6%
42.8%
<0.001
Comorbid conditions
Amputation
4.6%
3.6%
<0.001
CHF
23.0%
21.0%
<0.001
COPD
21.0%
18.0%
<0.001
CVA
7.9%
3.8%
<0.001
DM
28.0%
25.0%
<0.001
HTN
76.0%
75.0%
<0.001
MI
8.6%
6.0%
<0.001
PVD
16.0%
15.0%
<0.001
Valve
13.0%
5.0%
<0.001